SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 162 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $356,846 | +28.0% | 371,752 | -0.0% | 0.00% | – |
| Q1 2023 | $278,700 | +171937.0% | 371,792 | -15.4% | 0.00% | – |
| Q4 2022 | $162 | -99.9% | 439,723 | 0.0% | 0.00% | – |
| Q3 2022 | $189,000 | -47.2% | 439,723 | -4.4% | 0.00% | – |
| Q2 2022 | $358,000 | -47.6% | 459,885 | -13.2% | 0.00% | – |
| Q1 2022 | $683,000 | -41.6% | 529,945 | -42.4% | 0.00% | – |
| Q4 2021 | $1,170,000 | -61.8% | 920,723 | -34.4% | 0.00% | -100.0% |
| Q3 2021 | $3,061,000 | -55.6% | 1,403,926 | -23.6% | 0.00% | -50.0% |
| Q2 2021 | $6,892,000 | +5.6% | 1,837,653 | -7.9% | 0.00% | 0.0% |
| Q1 2021 | $6,525,000 | +17.0% | 1,995,802 | +22.1% | 0.00% | 0.0% |
| Q4 2020 | $5,575,000 | -28.6% | 1,634,231 | -14.6% | 0.00% | -33.3% |
| Q3 2020 | $7,804,000 | +29.0% | 1,912,641 | +6.8% | 0.00% | 0.0% |
| Q2 2020 | $6,050,000 | +41.9% | 1,790,354 | -2.1% | 0.00% | +50.0% |
| Q1 2020 | $4,263,000 | -23.4% | 1,829,577 | +19.6% | 0.00% | 0.0% |
| Q4 2019 | $5,566,000 | -48.9% | 1,529,197 | +16.5% | 0.00% | -50.0% |
| Q3 2019 | $10,893,000 | +3.1% | 1,312,984 | +7.0% | 0.00% | 0.0% |
| Q2 2019 | $10,570,000 | -2.3% | 1,227,639 | +21.3% | 0.00% | 0.0% |
| Q1 2019 | $10,817,000 | +23.6% | 1,011,905 | +1.2% | 0.00% | 0.0% |
| Q4 2018 | $8,753,000 | -29.2% | 1,000,245 | +35.9% | 0.00% | -20.0% |
| Q3 2018 | $12,369,000 | -47.3% | 736,284 | -34.2% | 0.01% | -44.4% |
| Q2 2018 | $23,456,000 | -39.7% | 1,119,037 | -53.7% | 0.01% | -43.8% |
| Q1 2018 | $38,905,000 | -16.6% | 2,417,948 | -1.8% | 0.02% | -15.8% |
| Q4 2017 | $46,673,000 | +30.4% | 2,462,907 | -3.2% | 0.02% | +18.8% |
| Q3 2017 | $35,803,000 | +79.7% | 2,544,901 | -4.9% | 0.02% | +77.8% |
| Q2 2017 | $19,926,000 | +38.6% | 2,674,679 | +21.0% | 0.01% | +28.6% |
| Q1 2017 | $14,373,000 | +64.6% | 2,211,245 | +12.2% | 0.01% | +75.0% |
| Q4 2016 | $8,730,000 | +4.5% | 1,970,631 | +10.1% | 0.00% | -20.0% |
| Q3 2016 | $8,357,000 | -8.3% | 1,789,613 | +29.0% | 0.01% | 0.0% |
| Q2 2016 | $9,111,000 | +17.0% | 1,386,763 | +13.3% | 0.01% | 0.0% |
| Q1 2016 | $7,785,000 | +7.3% | 1,224,059 | +1.7% | 0.01% | 0.0% |
| Q4 2015 | $7,255,000 | -1.8% | 1,203,127 | -2.6% | 0.01% | 0.0% |
| Q3 2015 | $7,386,000 | -12.8% | 1,235,158 | -0.2% | 0.01% | 0.0% |
| Q2 2015 | $8,468,000 | +11.5% | 1,238,002 | -1.1% | 0.01% | 0.0% |
| Q1 2015 | $7,598,000 | -12.5% | 1,251,650 | -0.1% | 0.01% | -16.7% |
| Q4 2014 | $8,686,000 | -14.3% | 1,253,467 | +0.7% | 0.01% | -14.3% |
| Q3 2014 | $10,131,000 | -0.2% | 1,244,567 | -0.3% | 0.01% | 0.0% |
| Q2 2014 | $10,148,000 | +3.2% | 1,248,240 | -0.5% | 0.01% | 0.0% |
| Q1 2014 | $9,834,000 | -11.7% | 1,254,315 | -0.4% | 0.01% | -22.2% |
| Q4 2013 | $11,141,000 | +4.2% | 1,258,915 | -1.2% | 0.01% | 0.0% |
| Q3 2013 | $10,691,000 | +10.8% | 1,274,245 | -1.4% | 0.01% | 0.0% |
| Q2 2013 | $9,646,000 | – | 1,292,991 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,020,583 | $15,053,000 | 1.77% |
| Piermont Capital Management Inc. | 247,882 | $1,847,000 | 0.53% |
| BARD ASSOCIATES INC | 129,380 | $964,000 | 0.44% |
| Sonora Investment Management, LLC | 239,202 | $1,782,055,000 | 0.34% |
| TFS CAPITAL LLC | 97,526 | $727,000 | 0.28% |
| Alambic Investment Management, L.P. | 165,001 | $1,229,000 | 0.15% |
| KENNEDY CAPITAL MANAGEMENT LLC | 491,075 | $3,659,000 | 0.07% |
| Renaissance Technologies | 6,071,817 | $45,235,000 | 0.06% |
| Granite Investment Partners, LLC | 97,023 | $723,000 | 0.05% |
| ClariVest Asset Management LLC | 241,909 | $1,802,000 | 0.04% |